Drug Profile
Numonafide - Panther Biotechnology
Latest Information Update: 27 Apr 2023
Price :
$50
*
At a glance
- Originator Northwestern University
- Developer Northwestern University; Panther Biotechnology
- Class Antineoplastics; Isoquinolines; Naphthalimides; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Haematological malignancies; Solid tumours
Most Recent Events
- 25 Apr 2023 Discontinued - Preclinical for Acute myeloid leukaemia in USA (unspecified route)
- 25 Apr 2023 Discontinued - Preclinical for Haematological malignancies in USA (unspecified route)
- 25 Apr 2023 Discontinued - Preclinical for Solid tumours in USA (unspecified route)